Conclusion: The MIS procedures were more effective than open surgeries in the treatment of hallux valgus. Moreover, the MIS group achieved better radiologic and clinical outcomes compared with the open group.
PubMed 35388365 ↗Dmaa
The short answer. People are split on Dmaa — 43% of 41 say it helped. It is most often used for energy: 92% of 25 reports say that improved. There is a moderate body of research — 9 meta-analyses and 8 trials. The most common complaint is jitteriness.
From 98 mentions in total — the rest didn't say how it went and aren't counted.
What Dmaa does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 9 meta-analyses on PubMed ↗ · 8 randomized trials ↗
Conclusion: :Memantine 20 mg/day caused a clinically noticeable reduction in deterioration over 28 weeks in patients with moderate to severe Alzheimer disease. This was supported by less functional and cognitive deterioration. Patients taking memantine were less likely to become agitated. The effect in mild to moderate AD is unknown. Patients with mild to moderate vascular dementia receiving memantine 20 mg/day had less cognitive deterioration at 28 weeks but the effects were not clinically discernible. There is an early beneficial effect on cognition, mood, behaviour and clinical impression for memantine
PubMed 15495043 ↗Conclusion: There is a beneficial effect of memantine (20 mg/day) for patients with moderate to severe Alzheimer disease on cognition and functional decline but not in the clinical impression of change. Patifor patients with moderate to severe Alzheimer disease on cognition and functional decline but not in the clinical impression of change. Patients with mild to moderate vascular dementia receiving memantine 20 mg/day had less cognitive deterioration at 28 weeks but again this effect was not clinically discernible. There is a possible beneficial effect on cognition, function and global scales for memanti
PubMed 12917950 ↗Conclusion: Memantine is a safe drug and may be useful for treating Alzheimer's, vascular,and mixed dementia of all severities. Most of the trials so far reported have been small and not long enough to detect clinically important benefits. However there is a possible benefit on cognition and global measures, and an early improvement in behaviour in people with dementia. More studies are needed.
PubMed 12535459 ↗2 human trials on ClinicalTrials.gov test Dmaa — 2 completed. See all on ClinicalTrials.gov ↗
- Functional and Radiographic Outcomes of Hallux Valgus Correction by Mini-invasive Surgery With Reverdin-Isham Percutaneous Osteotomy · Hallux Valgus · 2021
- Pharmacokinetic Effects of Oral DMAA · Outcomes of Single Oral Dose · 2012
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
6 reports name a product containing Dmaa (2015–2022); 4 involved hospitalization or worse. Most often reported:
- Death · 1
- Nonspecific reaction · 1
- Nausea · 1
- Cold sweat · 1
- Vomiting · 1
- Hallucination · 1
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The FDA found Dmaa as an undeclared ingredient in 5 products sold as supplements, most recently on 2026-05-05. FDA tainted-products database ↗
NIH has funded 1 research project with Dmaa in the title (1985–1985). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“DMAA made my depression go away. It helped me get up in the morning with my cup of coffee... DMAA also worked just as well as my current adhd medication (Vyvanse 50mg)”
“DMAA - tried 4 times. Feel jittery for a little while and it's hard to concentrate... then I crash and just want to nap.”
“The DMAA can certainly give you energy for your workouts but it can also cause a pretty nasty crash that isn't quite worth the energy for me personally.”
“I've experimented with DMAA as well, but that seems to have some unwanted side effects.”
Other options for energy
Sources
- User reports: 98 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA tainted-products database ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate